| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Technology Officer | Chief Technology Officer
1 company
Harmon Cyrus is a Director at Olema Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $11.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 10,000 | $6.30 | $63,000.00 | -1.0% | +80.0% | +100.5% | |
| Jun 6, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 10,000 | $6.17 | $61,700.00 | -0.5% | +101.0% | +120.6% | |
| Nov 29, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Technology Officer | Sell | 400 | $24.76 | $9,904.00 | - | -78.6% | -87.8% | |
| Oct 19, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Technology Officer | Sell | 12,000 | $27.98 | $335,794.25 | -0.6% | -75.5% | -89.2% | |
| Sep 20, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Technology Officer | Sell | 12,000 | $26.30 | $315,600.00 | -1.1% | -63.8% | -87.9% | |
| Aug 19, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Technology Officer | Sell | 12,000 | $24.97 | $299,640.00 | -1.1% | -3.0% | -84.6% | |
| Jul 20, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Technology Officer | Sell | 12,000 | $25.10 | $301,258.40 | -0.5% | +12.0% | -81.5% | |
| Jun 18, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Technology Officer | Sell | 12,000 | $24.80 | $297,625.50 | -0.4% | +17.3% | -85.3% |